Max R. Johnson
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
-
- Immunotherapy and Immune Responses
Papers in
-
- SARS-CoV-2 and COVID-19 Research 8
-
- Immunotherapy and Immune Responses 1
- interferon and immune responses 1
- Co-authors
- Emma S. Winkler (1 shared paper)Adam L. Bailey (1 shared paper)David Baker (1 shared paper)Natasha M. Kafai (1 shared paper)Longxing Cao (1 shared paper)Rashmi Ravichandran (1 shared paper)Lauren P. Carter (1 shared paper)Michael Diamond (1 shared paper)
- Journals
- Science Translational Medicine (2 papers)Frontiers in Immunology (1 paper)Cell Host & Microbe (1 paper)Nature Structural & Molecular Biology (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Max R. Johnson
12 papers receiving 489 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 257
- Immunology 52
- Virology 10
- Molecular Biology 140
- Immunology and Allergy 9
Countries citing papers authored by Max R. Johnson
This map shows the geographic impact of Max R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max R. Johnson more than expected).
Fields of papers citing papers by Max R. Johnson
This network shows the impact of papers produced by Max R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max R. Johnson. The network helps show where Max R. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Max R. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 139 | |
| 2 | 2022 | 95 | |
| 3 | 2021 | 56 | |
| 4 | 2022 | 40 | |
| 5 | 2022 | 38 | |
| 6 | 2021 | 36 | |
| 7 | 2023 | 33 | |
| 8 | 2023 | 15 | |
| 9 | 2025 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2024 | 10 | |
| 12 | Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma. | 2014 | 7 |
| 13 | 2022 | 0 |
About Max R. Johnson
Max R. Johnson is a scholar working on Infectious Diseases, Immunology, Virology, Immunology and Allergy and Genetics, having authored 13 papers that have together received 496 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), HIV Research and Treatment (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Malaria Research and Control (1 paper), Glioma Diagnosis and Treatment (1 paper), Immunotherapy and Immune Responses (1 paper), Cell Adhesion Molecules Research (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Infectious Diseases (257 citations), Immunology (52 citations), Virology (10 citations), Molecular Biology (140 citations) and Immunology and Allergy (9 citations). Max R. Johnson has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Emma S. Winkler, Adam L. Bailey, David Baker, Natasha M. Kafai, Longxing Cao, Rashmi Ravichandran, Lauren P. Carter, Michael Diamond, Minh Nguyet Pham and Pei‐Yong Shi. Their work appears in journals such as Science Translational Medicine, Frontiers in Immunology, Cell Host & Microbe, Nature Structural & Molecular Biology and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.